Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
24 Cards in this Set
- Front
- Back
When did the Framingham heart study start |
1948 |
|
What are the benefits of Qrisk |
UK data Includes additional risk factors such as ethnicity and deprivation |
|
What to do if Qrisk over 10 |
10% risk in next 10 years Prescribe statins |
|
When not to use Qrisk |
Type 1 diabetes Low GFR Familial hypercholesterolaemia |
|
What are the levels of blood lipids to send to specialist for hyperlipidaemia |
>9 total cholesterol >7.5 non HDL |
|
What is a commonly prescribed statin |
Atorvastatin |
|
What’s the dose of atorvastatin for primary prevention |
20mg |
|
What’s the dose for 2nd prevention atorvastatin |
80mg (Angina/ mi/ CAD |
|
Why treat asymptomatic disease (lipid profile) |
Reduce atherosclerotic process and incidence of CVD Prevent pancreatitis |
|
What set of patients commonly have severely raised triglycerides |
Alcoholics |
|
What does the LDL receptor recognise |
ApoB100 |
|
Where are he majority f LdLr found |
Liver |
|
What’s ezetimibe |
Potent selective inhibitor of absorption of cholesterol from small bowel |
|
How does ezitimibe reduce serum cholesterol |
Less dietary cholesterol and also less biliary cholesterol. Means less initially packages into VLDL |
|
How do resins work |
Bind bile acids in intestine (interrupt circulation of bile) |
|
How do fibrates work |
Bonds to nuclear PPar Increase peripheral lipolysis and decrease hepatic triglyceride production |
|
How does omega 3 work |
Inhibit lipogenesis and stimulate beta- oxidation. Reduced secretion of VLDL |
|
PCSK9 inhibitors |
PCSK9 binds to LDL receptors and promotes degradation PCSK9 inhibitors increase the availability of LDLR and remove LDL cholesterol from circulation |
|
What is the profile of hypercholesterolaemia |
Raised total cholesterol and LDL cholesterol (above 9mmol) |
|
What’s mixed hyperlipidaemia |
Raised TC and LDLc also raised TGs and low HDLC |
|
Likely presentation of high TC levels |
Xanthoma Arcus in eye |
|
How many people with FH |
1 in 200 |
|
How is FH passed on |
Autosomal dominant |
|
What causes familial hypercholesterolaemia |
Mutations in LDLR/ ApoB Gain of function mutation PCSK9 |